Syndecan-1 knockdown inhibits the proliferation and invasion of A172 glioblastoma multiforme cells
10.3969/j.issn.1002-0152.2016.02.003
- VernacularTitle:Syndecan-1基因沉默抑制胶质瘤A172细胞增殖和侵袭
- Author:
Shuang SHI
;
Dong ZHONG
;
Bing WANG
;
Wentao WANG
;
Fuan ZHANG
;
Haoyang HUANG
- Publication Type:Journal Article
- Keywords:
Glioma;
Syndecan-1;
Proliferation and Invasion
- From:
Chinese Journal of Nervous and Mental Diseases
2016;42(2):74-79
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of syndecan-1 (SDC1) in glioma cells and the effects of synde?can-1 knockdown on the proliferation and invasion of A172 cells. Methods The expression of syndecan-1 in glioma cells was analyzed using quantitative Real-time PCR and Western blotting. A172 cells were transfected with lentiviral vector carrying SDC1 shRNA to establish a stable SDC1-silencing cell line. The cell proliferation was analyzed by MTT assay. Trypan blue exclusion assay and flow cytometry, and Transwell assays were performed to measure the migration and invasion abilities, respectively. The mRNA and protein and expression levels of SDC1, Proliferation Cell Nuclear An?tigen (PCNA) and Matrix Metalloproteinase 9 (MMP-9) were detected by using qRT-PCR and Western blotting. Results The expression levels of SDC1 were significantly different in different glioma cell lines. The stable SDC1-silencing cell line was successfully established, in which the mRNA and protein expression levels of SDC1 were significantly decreased (P<0.05). SDC1 knockdown significantly reduced the cell proliferation, migration(58.40±5.24 vs. 255.8±16.09、226.5± 22.84,F=126.4,P<0.05)and invasion(61.67 ± 16.26 vs. 233.70 ± 17.24、244.30 ± 28.15,F=69.87,P<0.05)compared with either control group or blank group. SDC1 knockdown also significantly decreased the mRNA and protein expression levels of PCNA and MMP-9 (P<0.05). Conclusion:SDC1 knockdown suppresses the capacities of proliferation, invasion and migration of glioma A172 cell, implying that SDC1 may serve as a novel target in the biotherapy of glioma.
